These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9766918)

  • 21. Lymphoma, hairy-cell leukemia respond to new agents.
    Oncology (Williston Park); 1992 Sep; 6(9):94. PubMed ID: 1449980
    [No Abstract]   [Full Text] [Related]  

  • 22. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
    Spiers AS
    Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal expansion of large granular lymphocytes with a CD4+ CD8dim+/- phenotype associated with hairy cell leukemia.
    Airò P; Rossi G; Facchetti F; Marocolo D; Garza L; Lanfranchi A; Prati E; Brugnoni D; Malacarne F; Cattaneo R
    Haematologica; 1995; 80(2):146-9. PubMed ID: 7543070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Successful treatment of hairy cell leukemia with pentostatin].
    Fujita H; Koharazawa H; Nishida H; Terada S; Morishita T; Kuroyama Y; Ohata M; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Jul; 42(7):537-42. PubMed ID: 11524843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues.
    Larsen CR; Hansen PB; Clausen NT
    Am J Hematol; 2002 May; 70(1):48-50. PubMed ID: 11994981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alpha interferon treatment in hairy cell leukemia].
    Hagberg H
    Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
    Lauria F; Rondelli D; Zinzani PL; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura MA; Birtolo S; Forconi F; Tura S
    Leukemia; 1997 May; 11(5):629-32. PubMed ID: 9180283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hairy cell leukemia-variant--a case report.
    Gupta K; Jasmina A; Malhotra P; Varma N; Vaiphei K; Vohra H; Varma S; Garewal G
    Indian J Pathol Microbiol; 2005 Jul; 48(3):387-9. PubMed ID: 16761764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hairy cell leukaemia: review of treatment.
    Kurzrock R; Talpaz M; Gutterman JU
    Br J Haematol; 1991 Oct; 79 Suppl 1():17-20. PubMed ID: 1718389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hairy-cell leukemia: current views.
    Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
    Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [European-American-type hairy cell leukemia without splenomegaly, treated successfully with deoxycoformycin].
    Muta T; Okamura T; Oshima K; Kikuchi M; Niho Y
    Rinsho Ketsueki; 2001 May; 42(5):426-31. PubMed ID: 11452464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
    Sokol L; Agosti SJ
    Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
    Dearden CE; Matutes E; Catovsky D
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic lymphocytic leukemia and hairy-cell leukemia.
    Cheson BD
    Curr Opin Oncol; 1991 Feb; 3(1):54-62. PubMed ID: 1710506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2'-deoxyadenosine (CdA): relation to opportunistic infections.
    Juliusson G; Liliemark J
    Blood; 1992 Feb; 79(4):888-94. PubMed ID: 1346578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment.
    Robak T
    Cancer Treat Rev; 2011 Feb; 37(1):3-10. PubMed ID: 20558005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of alpha-interferon in the treatment of hairy-cell leukemia].
    Pagnucco G; Castelli G; Lazzarino M; Bernasconi C
    Haematologica; 1990; 75 Suppl 4():56-67. PubMed ID: 2074056
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the treatment of hairy-cell leukaemia.
    Mey U; Strehl J; Gorschlüter M; Ziske C; Glasmacher A; Pralle H; Schmidt-Wolf I
    Lancet Oncol; 2003 Feb; 4(2):86-94. PubMed ID: 12573350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.